07 March 2012
Guidelines Development And Objective
The development group for these guidelines consisted of cardiologists (adult and paediatric), pulmonologists, and cardio thoracic surgeons from the Ministry of Health and Institut Jantung Negara, Malaysia. This is the first edition of the PAH CPG. These guidelines have been issued in 2011 and will be reviewed in 2015 or sooner if new evidence becomes available.
These guidelines provide:
a) A description of Pulmonary Arterial Hypertension (PAH) which reflects the devastating nature of PAH that have crucial bearing on the patient’s management
b) A description of the basic pathophysiology of PAH
c) A brief discussion on the Dana Point Classification (2008) and WHO Functional Class Classification
d) Guidance on the recognition of clinical features and diagnostic approach of PAH.
e) An algorithm on treatment of PAH with available therapies locally
f) A guide on PAH disease monitoring in accordance with dynamic changes with therapy or with disease progression
g) A guide on management of PAH in congenital heart disease.
To download the full report, please login to the member section...